Case Study: Henry Ford Health achieves 50% faster study start-up with WCG Clinical

Henry Ford Health cuts study start-up timelines by 50% with WCG Clinical

Henry Ford Health, a leading academic medical center, faced challenges with long study start-up timelines and operational inefficiencies due to its decentralized clinical research model. This hindered its ability to build system-level relationships with sponsors and meet the National Cancer Institute's 90-day activation benchmark. To address this, HFH partnered with WCG Clinical for its integrated suite of IRB, IBC, and Study Start-Up services.

WCG Clinical provided a comprehensive solution, helping HFH centralize its pre-award processes and establish new internal workflows. This partnership resulted in a 50% decrease in study start-up timelines and enabled 100% compliance for coverage analysis. The total number of open trial protocols grew by 44%, from 863 to 1,246, between 2022 and 2024, allowing HFH to rapidly expand its research footprint.

Henry Ford Health